kstew call notes| call focus mako knee
margin outlook trauma extrem soft
report result market close stock trade lower after-market trade think initi after-market
trade reaction mainli due report sale dollar bit lighter thomson/street estim actual vs
street first time sale come street mean estim sinc quarter in-lin
higher perform flattish said organ sale ep street
stryker confer call finish littl bit ago quick takeaway call
managem ent express confid outlook manag note rais organ sale guidanc high end
prior rang increas ep outlook manag note ytd organ sale run around
expect fourth quarter
mako knee instal robot global us larg complet total knee upgrad quarter
robot call competit account averag market share util rate
increas y/i knee sale global us note continu take share ask
outlook other launch robot believ busi sticki wed agre check orthoped surgeon
survey result initi report
com it oper argin expans oper margin exclud impact quarter
manag reiter commit minimum improv margin note hold true even
dilut a/potenti manag comment hasnt chang long-term guidanc thu
take compani like reaffirm minimum give guidanc januari
traum extrem iti perform anc trauma extrem growth slower recent trend sale global
 manag note busi impact softer market product suppli issu latter
improv manag also note comp tough said market seem slow june note
happen past transitori felt good outlook new product launch
com petitiv env ironm ent said focus play offens said hasnt seen materi chang
approach custom
acquisit com entari manag comment strategi like continu similar past
 smaller tuck-in deal leverag exist call point adjac
dont forget inv estor day em ber new jersey
raw note earn call pleas feel free reach question
pleas note commentari verbatim note abbrevi
organ sale grow th approxim strong top line momentum continu reflect strength diversifi
neurotechnolog spine standout ith organ grow th neurotechnolog grew
medsurg post gain ith instrument lead ay
orthoped increas approxim driven grow th knee mako continu gain traction approach
robot global continu feel bullish futur robotic-assist surgeri
 ith strong organ sale grow th oper margin expans deliv ep tow ard high end target
quarter
given solid perform ytd convict outlook rais guidanc organ sale grow th ep
katherin owen vice-president strategi investor relat commentari
instal robot global ith us compar year-ago quarter ith us
upgrad total knee larg complet quarter
robot competit account ith either market share share ell averag
surgeon train bring total
us procedur total knee bring ytd ith procedur
mako procedur top quarter make total knee repres major roughli
pleas ith increas mako total knee data show ing clinic econom data studi publish bone joint journal hich
show ed surgeri perform singl surgeon overal studi conclud mako treat patient achiev statist
signific improv ith decreas pain improv earli function recoveri reduc time hospit discharg compar
 ith convent knee surgeri patient treat ith mako ere discharg full day earlier tradit knee surgeri
patient hip knee societi publish paper compar episod care cost ith patient receiv mako total knee
versu convent studi show ed mako episod care cost ere less convent facil cost length
stay ere also less ith mako mako patient ere discharg less skill nurs facil readmiss
reduct outcom measur studi ere statist significantli favor mako-assist knee replac
overal pleas ith adopt enabl drive meaning knee share
late august announc deal billion
highlight complementari innov product portfolio
 ith addit portfolio track record execut robust pipelin spine ell posit
ceo eric major ill join presid spine divis
organ sale grow th quarter sell day sell day ill meaning impact fy
quarter price unfavor hile fx unfavor impact sale
us organ sale grow th intern organ sale grow th
adjust ep increas y/i reflect strong drop sale grow th oper expens control
signific impact fx
orthoped constant currenc organ grow th
us perform organ grow th us highlight knee knee continu see high demand mako
print product trauma extrem impact softer market product suppli issu latter ill impact
expect acceler
grow th strength europ emerg market australia
constant currenc grow th organ grow th
us perform organ grow th us instrument us organ includ perform includ pow er
commun proservic busi novadaq organ medic us organ grow th reflect solid perform
pc physio drive signific amount grow th easi comp medic face tough comp core medic
offset impact impact medic organ grow th impact stryker overal medic core capit
solid pipelin expect drive strong
grow th organ ith good perform emerg market australia japan
sale grow th constant currenc organ grow th reflect doubl digit across neurotech busi
less market headw ind core spine
us perform us neurotech sale ere organ driven hemorrhag cmf neuro-pow ere instrument
pleas ith entellu integr spine double-digit grow th ivf tritanium implant
 spine organ high demand across geographi
adopt reclassifi expens sg sale
gross margin y/i compar prior year favor comp includ eather product ineffici
partial off-set price fx busi mix
 sale slightli higher prior year
sg line ith prior year quarter reflect focu oper expens improv cost transform
grow th ctg program includ key product indirect purchas share servic favor aris prior year
comp relat eather disrupt offset continu plan ctg invest like erp rite-off
softw asset neg impact acquisit hich notabl higher dilut vs prior year
oper margin favor op margin reflect good leverag ctg invest acquisit hich ere
neg impact quarter remain confid deliv improv oper margin
expens decreas due favor interest incom
tax reflect underli tax rate off-set benefit stock comp
maintain cash/equv hich held ou total debt unchang billion
op ytd increas earn low er recal relat off-set tax payment payment relat
expect organ sale grow th high end full year day
given ytd perform momentum ep
expect ep
guidanc includ anticip impact busi invest relat entrullu potenti dilut deal
may close quarter full year ep fx favor
 question manag responsepleas note verbatim
oper margin back oper margin expans see busi
go forward back minimum margin expans hold true even ith dilut ith
potenti fairli good gross margin perform includ mix price product ineffici start see
save ctg program feel strong make minimum
think guidanc rais upper end rang go reflect quarter
tailw ind endo come end cycl ith gear launch camera ytd expect
fourth quarter neurotech might moder hair feel good grow th outlook
confid continu grow rel year five year increas organ
grow th year-over-year med-tech market rise outpac grow th go next year think ill
lot product number new launch feel good cadenc new product feel like good
posit continu ith strong organ sale grow th past year
mako mention win competit account think sticki busi think
safe say given cost million robot invest surgeon train staff train get familiar think
sticki hy think competit advanc term definit robot hat close
robot global healthi pipelin start see clinic econom data come specif robot think
sticki busi get robot think benefit jig-less option
trauma softest seen talk market soft suppli issu give view ere
disappoint ith perform quarter tough comp quarter littl suppli disrupt
expect resolv extrem grew littl less expect pick new product launch
market slow dow saw sinc june happen past transitori feel good ith new product
launch busi ill pick suppli issu larg resolv ill notic
mako field upgrad complet go aggress new account think lot runw ay
potenti place thousand hospit us also ork ith surgeon hospit lot runw ay
robot placement ith upgrad complet focu ill place new robot
invuiti acquisit acquisit rational fit long term strategi vision light retractor
enter advanc energi space ith novel product focus ast manag surgic technolog one
busi unit fit realli ell ith call point instrument peopl novel technolog high
mako data what pipelin go see steadi cadenc clinic side ork ith kol ho initi studi
 ith launch eventu ill year data thrill ith first studi note ith patient arm
still hit signific year data possibl august next year that hat need publish peer review journal
comp normal ill easier comp biggest impact last year normal ould
occur middl next year
mako look like sequenti system placement season think need look y/i alw ay
softer quarter reconstruct usual see meaning step interest level high
margin commit commit base hat know today hat pipelin havent
chang long term guidanc
doubl spine acquisit signal feel optimist spine market
signal spine strateg need get bigger think consist past year import
commit ith spine synergist ith neurotechnolog orthoped busi market commit
time ork ell realli develop stronger stronger perform deal vari gotten know
compani ell bring ceo run spine busi cultur similar nice see market
stabil hope ill improv think ill enhanc grow th overal spine busi
ftc issu deal dont anticip issu
mako what mix leas versu purchas besid capit implant sale forc flex spend sale
forc ork financ need robot sold go get break-out
neurotech neurovascular group tremend year double-digit grow th ischem hemorrhag surpass flow
divert stent approv ill ramp launch late year earli part next year earli stage launch
aspir product look ahead market expans ischem new product launch feel good
fx impact look fx expect slight neg impact sale due translat neglig impact sale ep line
off-set transact fx hedg program
tax rate underli ytd report better full year effect tax rate think
effect ill low er end rang see compar slightli higher tax rate driven new tax
preview analyst meet give color beyond guidanc ill
earn call januari
hip perform trident hip cup ramp hen say ramp take time slight pick hip number
expect continu feedback good ell receiv field stock ith set expect
see pick hip busi sale forc also focus knee
 youv activ tuck-in deal think deal go-forward basi consist ith hat
tend smaller mid-siz adjac ould expect see similar pattern hat done
comment acceler growth spine busi play driver move spine
busi ithin spine innov alw ay tritanium product commit drive innov spine combin
organ ill lot impact
mako placement what right think doc ramp procedur tend coupl case
wait grow case hat see interest go surgeon champion gradual
increas procedur could take anyw month use procedur
effect tax rate what excess stock compens benefit much differ
trauma extrem break suppli issu side difficult year-over-year comparison
new product come market slow dow sinc june happen year seen
market grow th slow bit hat know seem market slow dow quarter
hyperbranch acquisit fit fit ithin cmf busi hich ithin neurotechnolog segment
 product gap didnt dural sealant product excit add product tuck exist busi
price look like got littl wors quarter anyth call fundament end price thought
 ould mix play chang hat think
spine deal tend dis-synergi assumpt view longer term dilut
affirm long-term guidanc oper margin expans go break assumpt ith sale dis-
synergi ith minim custom overlap use agent direct sale rep comfort ith model
spine robot thought focus optim knee also project underw ay ith applic
spine shoulder posit talk time number applic expand right
focu knee ant come market ith someth meaning ith benefit
total knee move inpati list impact see risk go forward anyth improv
hop reimburs level havent seen dynam chang sinc hospit outpati reimburs ould
caus chang dont see short term happen overal market fairli healthi fairli stabl
seen increment competit headwind look number perform focus ow offens drive
mako print continu focu offens havent seen materi chang approach custom
neurotech els drive ithin instrument coupl neuro-pow er drill sonopet product tumor ablat
malic product suit product neurosurgeon intern innov small tuck-in neurosurg
pow er tool grow ing fast neurovascular cmf doubl digit grow th across portfolio
siemen partnership strateg allianc provid imag think compet ith tri bundl
 arm ensur competit bundl offer
emerg market environ three quarter double-digit grow th feel good busi china latin america turkey
russia india hire new manag director ork get back foot outlook posit
go take time havent made degre invest other market dynam good like
chanc
think sustain growth busi regain market share get back offens
think ill doubl digit grow th busi
mako competitor view market start ith hat robot capabl hat valu bring
flex financi tremend valu us ith close robot global hat pipelin model
 ork us
date call januari novemb analyst meet product fair
kristen stew art cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens
 ill directli indirectli relat specif recommend view express research report
